Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:16 AM
Ignite Modification Date: 2025-12-25 @ 4:16 AM
NCT ID: NCT04848220
Eligibility Criteria: Inclusion Criteria: * Stable angina participants suitable for elective PCI, or participants suitable for PCI for diagnosis of non-ST-elevation myocardial infarction or unstable angina (NSTEMI/UA) who are consistently hemodynamically stable until the time of PCI and have a thrombolysis in myocardial infarction (TIMI) Flow Grade 2 or 3 on the diagnostic angiography * Target lesions for PCI must appear suitable for stenting as confirmed on the diagnostic angiography and must satisfy the study criteria regarding lesion size and vessel diameter/type. * Females must not be of childbearing potential * Males with pregnant or non-pregnant female partners of childbearing potential must agree to using a condom during treatment and for 90 days following treatment Exclusion Criteria: * Planned or anticipated use of rotational atherectomy/ablation or shockwave therapies during the PCI procedure * Any history of stroke, seizure, intracranial bleeding, or intracranial aneurysm * Transient ischemic attack within the 6 months prior to Screening * History of major trauma, major surgery, and/or clinically significant head injury or hemorrhage within the last 6 months of Screening * Any ST-elevation myocardial infarction (STEMI) within 10 days of Screening or STEMI within the target vessel territory within the last 4 months of Screening
Healthy Volunteers: False
Sex: ALL
Minimum Age: 30 Years
Maximum Age: 80 Years
Study: NCT04848220
Study Brief:
Protocol Section: NCT04848220